Trial Information

Summary: Treatment research study for advanced non-small cell lung cancer

Non-small cell lung cancer that has spread to other parts of the body (known as metastasis) is often treated with a combination of chemotherapy drugs. The purpose of this study is to evaluate a drug that is not a traditional chemotherapy drug, but rather is meant to enhance the effectiveness of other standard chemotherapy treatments. This study will evaluate whether this investigational drug can improve the effectiveness of a chemotherapy regimen consisting of cisplatin and vinorelbine, a commonly used combination for advanced non-small cell lung cancer.

A physician participating in the study will determine eligibility, but if you meet the following criteria, you may qualify for this study:

• Stage IIIb or Stage IV.NSCLC (advanced disease)
• No evidence of brain metastasis
• No prior chemotherapy for advanced disease
• No treatment with any investigational drug or radiation within 30 days prior to beginning treatment with study drug
• Must be inoperable disease (not curable with surgery)

If you or someone you know has been diagnosed with non-small cell lung cancer and are interested in participating in this study, please call toll free.

If you would like to learn more about participating in this study, please send an e-mail message using the form below.